Tim Funnell
Partner • Monograph Capital
Tim trained as a Pharmacologist with Undergraduate degree from University of Cambridge and DPhil from the University of Oxford before joining the Boston Consulting Group’s London office. Since then Tim has been a biotech investor and company-builder at Syncona, Third Rock Ventures, and Oxford Sciences, gaining experience across therapeutic modalities and geographies. Tim leads Monograph’s investments in Aviado and Ascend.
Also speaking
Event Info
Spotlight Roundtables
Take a look at the sample attendee list for Advanced Therapies Europe here.
8 August 2022
